Compare XBIO & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIO | GFAI |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 5.5M |
| IPO Year | 2011 | 2020 |
| Metric | XBIO | GFAI |
|---|---|---|
| Price | $1.66 | $0.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.3K | ★ 206.3K |
| Earning Date | 11-24-2026 | 09-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,976,411.00 | N/A |
| Revenue This Year | $2.37 | $11.88 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.04 | N/A |
| 52 Week Low | $1.58 | $0.17 |
| 52 Week High | $4.94 | $0.98 |
| Indicator | XBIO | GFAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 34.68 |
| Support Level | $1.58 | N/A |
| Resistance Level | $3.21 | $0.41 |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 22.89 | 29.02 |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific region. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, and Corporate and others. The majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions. Geographically, the company generates maximum revenue from Thailand.